No press releases found.
Corcept, Revolution Medicines lead ten large-cap healthcare stocks surging in 2026
Seeking Alpha News (Mon, 17-Aug 8:26 AM ET)
Notable healthcare headlines for the week: Eli Lilly, Hims & Hers Health, and Merck in focus
Seeking Alpha News (Sun, 16-Aug 9:05 AM ET)
S&P 500 posts weekly gain as strength spreads beyond technology
Seeking Alpha News (Fri, 14-Aug 4:18 PM ET)
Earnings optimism broadens: health care, industrials, and real estate join tech
Seeking Alpha News (Thu, 13-Aug 2:35 PM ET)
State Street Health Care Select Sector SPDR ETF seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. The Fund may invest in cash and cash equivalents or money market instruments, such as repurchase agreements and money market funds. The Index includes companies that have been identified as Health Care companies by the Global Industry Classification Standard (GICS), including securities of companies from the following industries: pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and health care technology. The Index is one of eleven Select Sector Indexes developed and maintained in accordance with the following criteria: (1) each of the component securities in the Index is a constituent of the S&P 500 Index; and (2) the Index is calculated by S&P Dow Jones Indices LLC ("S&P DJI") based on a proprietary "modified market capitalization" methodology which means that modifications may be made to the market capitalization weights of single stock concentrations.
State Street Health Care Select Sector SPDR ETF trades on the ARCA stock market under the symbol XLV.
As of August 18, 2026, XLV stock price climbed to $169.83 with 2,539,717 million shares trading.
XLV has a beta of 0.22, meaning it tends to be less sensitive to market movements. XLV has a correlation of 0.03 to the broad based SPY ETF.
XLV has a market cap of $44.40 billion. This is considered a Large Cap stock.
In the last 3 years, XLV traded as high as $170.30 and as low as $122.59.
XLV has outperformed the market in the last year with a price return of +26.5% while the SPY ETF gained +20.5%. XLV has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +17.5% and +4.7%, respectively, while the SPY returned +4.1% and +1.3%, respectively.
XLV support price is $165.00 and resistance is $169.10 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XLV shares will trade within this expected range on the day.